Sunday, January 13, 2019 11:27:15 AM
I will say this,,,Once the FDA shows interest in them and they get close to uplist, the pps will more than improve to and past the $4 level.
If all goes well, they will be taken out by a much bigger player.
Alotta this can happen on an uplist only, but if they show promise(they already do), and with a little FDA nudge, great things can/will happen, IMO.
Does the FDA have alot to say in their products? I would guess yes because they affect wellbeing of patients even tho from a data perspective.
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM